Markets
BSE See NSE See 39,116.58
-335.49 (-0.85%)
collapse Related Readings collapse

Torrent Pharma: Recommendation Review

| 4/5/2012 9:00 PM Thursday

We had recommended Torrent Pharma in DSIJ Vol. 26, Issue No. 25 (dated November 21-December 4, 2011), when
it was trading at Rs 559. After seeing a downtrend in December, the scrip is now trading up by 11 per cent at Rs 623. Our reasons to recommend the counter were the consistent growth in its topline and also a better growth in its bottomline.

Torrent Pharma has consistently been a dividend paying company. The promoters have not pledged any of their shares, which indicates the confidence they have in the business. Its low debt-to-equity ratio was also a reason why we were very positive on the scrip in a high interest rate regime. In 2011, when all the indices were hammered, the counter remained very firm.

The company sells in the domestic as well as the export markets. It has products in various therapeutic segments, including specialty segments like diabetology, cardiovascular, Central Nervous System, etc. It recently launched 19 products in the gynaecology segment, and has about six products in the pipeline that are yet to be launched. Its business, which is well integrated with formulations, API and CRAMs, is also one of the reasons why we remain positive on the scrip.

For the first nine months of this fiscal, the company has reported a topline growth of 19 per cent to Rs 1946 crore, while its bottomline grew by 26 per cent to Rs 287 crore. Its EBITDA margins took a little beating due to the increase in input costs. We believe that the next quarter’s performance is already factored into the price of the stock. Hence, investors should take this opportunity to book profits at the current levels.

 

Find More Articles on: DSIJ Magazine, Reviews, Stock Recommendations, Fundamental Picks, Product, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

Index trend and stocks in action June 17, 2019

Karan DSIJ / Article rating: 5.0

In case Nifty falls below the level of 11,770, it may test the 11,600 mark in the near term. To move upside, the bulls need to move above the 20-DMA once again and sustain for at least two to three days. Only then, the bulls will gain confidence. Stocks in news: BHEL, Elecon Engineering Company, PG Electroplast, FDC, Divi’s Laboratories, Symphony, Coromandel International, Voltas.

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.